Skip to main content
SpringerLink
Log in

The Prevalence of High- and Low-Risk Human Papillomaviruses in the Russian Federation

  • EXPERIMENTAL PAPERS
  • Published:
Molecular Genetics, Microbiology and Virology Aims and scope Submit manuscript

Abstract

An assessment was made of high- and low-risk human papillomaviruses (HPVs) prevalence in the Russian Federation. Clinical samples (urogenital swabs) were obtained from male and female patients of different ages with supposed urogenital HPV infection living in different regions of the Russian Federation in 2019 (n = 12 945). HPV genotyping was performed using a real-time PCR Kvant-21 kit (DNA-Technology, Russia), which allows differentiating between the high-risk HPV types 31, 35, 52, 33, 68, 45, 82, 51, 39, 58, 66, 26, 53, 59, 56, 73, 16, and 18 and low-risk HPV types 6, 11, and 44. In the clinical samples obtained from 5013 patients, 8593 HPV strains were detected with HPV monoinfection being observed in 3057 patients and mixed infection in 1956 patients. It was shown that, in the Russian Federation, the dominant HPV-types are HPV16, 13.8% (95% CI 13.0–14.5); HPV6, 10.7% (10.0–11.3); HPV51, 6.8% (6.3–7.3); HPV44, 6.8% (6.2–7.3); HPV53, 6.3% (5.8–6.8); HPV31, 5.6% (5.2–6.2); HPV56, 5.5% (5.0–6.0); and HPV52, 5.4% (5.0–5.9), while the percentage of other types varied from 5 to 0.4%. The age, gender, and regional distribution of different HPV types has been described. The results of monitoring circulating HPV strains will allow the effectiveness to be predicted of HPV vaccines of different composition in the Russian Federation and may be used to a great extent in the development of Russian HPV vaccines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

REFERENCES

  1. de Villiers, E.M., Fauquet, C., Broker, T.R., Bernard, H.U., and zur Hausen, H., Classification of papillomaviruses, Virology, 2004, vol. 324, no. 1, pp. 17–27. https://doi.org/10.1016/j.virol.2004.03.033

    Article  CAS  PubMed  Google Scholar 

  2. Bzhalava, D., Eklund, C., and Dillner, J., International standardization and classification of human papillomavirus types, Virology, 2015, vol. 476, pp. 341–344. https://doi.org/10.1016/j.virol.2014.12.028

    Article  CAS  PubMed  Google Scholar 

  3. Harden, M.E. and Munger, K., Human papillomavirus molecular biology, Mutat. Res., Rev. Mutat. Res., 2017, vol. 772, pp. 3–12. https://doi.org/10.1016/j.mrrev.2016.07.002

    Article  CAS  Google Scholar 

  4. Bodily, J. and Laimins, L.A., Persistence of human papillomavirus infection: keys to malignant progression, Trends Microbiol., 2011, vol. 19, no. 1, pp. 33–39. https://doi.org/10.1016/j.tim.2010.10.002

    Article  CAS  PubMed  Google Scholar 

  5. de Martel, C., Plummer, M., Vignat, J., and Franceschi, S., Worldwide burden of cancer attributable to HPV by site, country and HPV type, Int. J. Cancer, 2017, vol. 141, no. 4, pp. 664–670. https://doi.org/10.1002/ijc.30716

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Serrano, B., Brotons, M., Bosch, F.X., and Bruni, L., Epidemiology and burden of HPV-related disease, Best Pract. Res. Clin. Obstet. Gynaecol., 2018, vol. 47, pp. 14–26. https://doi.org/10.1016/j.bpobgyn.2017.08.006

    Article  PubMed  Google Scholar 

  7. Chaturvedi, A.K., Beyond cervical cancer: burden of other HPV-related cancers among men and women, J. Adolesc. Health, 2010, vol. 46, no. 4, Suppl., pp. 20–26. https://doi.org/10.1016/j.jadohealth.2010.01.016

    Article  Google Scholar 

  8. Grulich, A.E., Jin, F., Conway, E.L., Stein, A.N., and Hocking, J., Cancers attributable to human papillomavirus infection, Sex. Health, 2010, vol. 7, no. 3, pp. 244–252. https://doi.org/10.1071/SH10020

    Article  PubMed  Google Scholar 

  9. Baranov, A.A., Plakida, A.V., Namazova-Baranova, L.S., Semenov, M.A., Ilyushina, O.V., Guretskiy, Ye.V., et al., Analysis of the economic and socio-demographic burden of HPV-associated diseases and the cost-effectiveness of HPV vaccination in Russia, Pediatr. Pharmacol., 2019, vol. 16, no. 2, pp. 101–110.

    Article  Google Scholar 

  10. Guan, P., Howell-Jones, R., Li, N., Bruni, L., de Sanjosé, S., Franceschi, S., and Clifford, G.M., Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer, Int. J. Cancer, 2012, vol. 131, no. 10, pp. 2349–2359. https://doi.org/10.1002/ijc.27485

    Article  CAS  PubMed  Google Scholar 

  11. Arbyn, M., Tommasino, M., Depuydt, C., and Dillner, J., Are 20 human papillomavirus types causing cervical cancer?, J. Pathol., 2014, vol. 234, no. 4, pp. 431–435. PMID https://doi.org/10.1002/path.4424

    Article  CAS  PubMed  Google Scholar 

  12. Poljak, M., Seme, K., Maver, P.J., Kocjan, B.J., Cuschieri, K.S., Rogovskaya, S.I., et al., Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe, Vaccine, 2013, vol. 31, no. 7, Suppl., pp. 59–70. https://doi.org/10.1016/j.vaccine.2013.03.029

    Article  Google Scholar 

  13. Rogovskaya, S.I., Shabalova, I.P., Mikheeva, I.V., Minkina, G.N., Podzolkova, N.M., Shipulina, O.Y., et al., Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia, Vaccine, 2013, vol. 31, no. 7, Suppl., pp. 46–58. https://doi.org/10.1016/j.vaccine.2013.06.043

    Article  Google Scholar 

  14. Kisseljova, N., Zhordania, K., Fedorova, M., Katargin, A., Valeeva, A., Pajanidi, J., et al., Detection of human papillomavirus prevalence in ovarian cancer by different test systems, Intervirology, 2019, vol. 62, nos. 5–6, pp. 198–204. https://doi.org/10.1159/000506050

    Article  CAS  PubMed  Google Scholar 

  15. Smelov, V., Elfstrom, K.M., Eklund, C., Sokolova, O., and Dillner, J., Determinants of the presence of human papillomaviruses in the anal canal of Russian men, J. Med. Virol., 2018, vol. 90, no. 10, pp. 1643–1650. https://doi.org/10.1002/jmv.25234

    Article  PubMed  Google Scholar 

  16. Roik, E., Sharashova, E., Kharkova, O., Nieboer, E., Postoev, V., and Odland, J.Ø., Sociodemographic characteristics, sexual behavior and knowledge about cervical cancer prevention as risk factors for high-risk human papillomavirus infection in Arkhangelsk, North-West Russia, Int. J. Circumpolar Health, 2018, vol. 77, no. 1, p. 1498681. https://doi.org/10.1080/22423982.2018.1498681

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kulmala, S.M., Shabalova, I.P., Petrovitchev, N., Syrjänen, K.J., Gyllensten, U.B., and Syrjänen, S.M., Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union, J. Med. Virol., 2007, vol. 79, no. 6, pp. 771–781. https://doi.org/10.1002/jmv.20839

    Article  PubMed  Google Scholar 

  18. Nazarova, N.M., Burmenskaya, O.V., Sulamanidze, L.A., Prilepskaya, V.N., Pavlovich, S.V., and Trofimov, D.Yu., Prevalence of anogenital HPV types in patients with HPV-associated diseases of the cervix uteri, Obstet. Gynecol. (Moscow), 2015, no. 12, pp. 89–96.

  19. Donnikov, A.E., Markelov, M.I., Pestrikova, T.Yu., Yurasova, E.A., Kotelnikova, A.V., Voroshilina, E.S., et al., Analysis of the prevalence and viral load of different human papillomavirus types in the regions of the Russian Federation, Obstet. Gynecol. (Moscow), 2019, no. 4, pp. 39–47. https://doi.org/10.18565/aig.2019.4.39-47

  20. Cohen, D.A., Farley, T.A., Taylor, S.N., Martin, D.H., and Schuster, M.A., When and where do youths have sex? The potential role of adult supervision, Pediatrics, 2002, vol. 110, no. 6, article no. e66. https://doi.org/10.1542/peds.110.6.e66

    Article  PubMed  Google Scholar 

  21. Bosch, F.X., Burchell, A.N., Schiffman, M., Giuliano, A.R., de Sanjose, S., Bruni, L., et al., Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia, Vaccine, 2008, vol. 26, no. 10, Suppl., pp. 1–16. https://doi.org/10.1016/j.vaccine.2008.05.064

    Article  Google Scholar 

  22. Lopalco, P.L., Spotlight on the 9-valent HPV vaccine, Drug Des. Dev. Ther., 2017, vol. 11, pp. 35–44. https://doi.org/10.2147/DDDT.S91018

    Article  CAS  Google Scholar 

  23. de Sanjose, S., Quint, W.G., Alemany, L., Geraets, D.T., Klaustermeier, J.E., Lloveras, B., et al., Retrospective International Survey and HPV Time Trends Study Group, Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study, Lancet Oncol., 2010, vol. 11, pp. 1048–1056. https://doi.org/10.1016/S1470-2045(10)70230-8

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

    E. B. Faizuloev, A. N. Kaira, T. R. Uzbekov, A. A. Poromov, E. A. Volynskaya, O. A. Svitich & V. V. Zverev

Authors
  1. E. B. Faizuloev
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. N. Kaira
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. R. Uzbekov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. A. Poromov
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. A. Volynskaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. O. A. Svitich
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. V. V. Zverev
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. B. Faizuloev.

Ethics declarations

Conflict of interest. The authors declare that they have no conflict of interest.

Statement of compliance with standards of research involving humans as subjects. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants involved in the study.

Additional information

Translated by E. Martynova

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Faizuloev, E.B., Kaira, A.N., Uzbekov, T.R. et al. The Prevalence of High- and Low-Risk Human Papillomaviruses in the Russian Federation. Mol. Genet. Microbiol. Virol. 36, 192–200 (2021). https://doi.org/10.3103/S0891416821040066

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3103/S0891416821040066

Keywords:

Search

Navigation